scholarly article | Q13442814 |
P356 | DOI | 10.1006/BBRC.1997.7493 |
P698 | PubMed publication ID | 9344858 |
P50 | author | Fabio Marra | Q37841541 |
Giovanni Raugei | Q56857081 | ||
P2093 | author name string | Ramponi G | |
Chiarugi P | |||
Camici G | |||
Cirri P | |||
Manao G | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 493-497 | |
P577 | publication date | 1997-10-01 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells | |
P478 | volume | 239 |
Q34018570 | A Phosphotyrosine Proteomic Screen Identifies Multiple Tyrosine Kinase Signaling Pathways Aberrantly Activated in Malignant Mesothelioma |
Q37334829 | A novel derivative of the natural agent deguelin for cancer chemoprevention and therapy |
Q40226278 | Activation of STAT3 by G alpha(s) distinctively requires protein kinase A, JNK, and phosphatidylinositol 3-kinase |
Q38312043 | Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity |
Q42801916 | Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity |
Q30449907 | An EGF receptor/Ral-GTPase signaling cascade regulates c-Src activity and substrate specificity |
Q34592824 | An endoplasmic reticulum stress-initiated sphingolipid metabolite, ceramide-1-phosphate, regulates epithelial innate immunity by stimulating β-defensin production |
Q74271438 | Biochemical and cellular effects of c-Src kinase-selective pyrido[2, 3-d]pyrimidine tyrosine kinase inhibitors |
Q40580990 | Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells |
Q38302598 | Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells |
Q40627260 | Constitutively active Galpha16 stimulates STAT3 via a c-Src/JAK- and ERK-dependent mechanism |
Q37075035 | Critical analysis of the potential for targeting STAT3 in human malignancy |
Q47622942 | Differential ability of SOCS proteins to regulate IL-6 and CSF-1 induced macrophage differentiation |
Q39191555 | Dynamin inhibitors impair endocytosis and mitogenic signaling of PDGF. |
Q33855769 | Early events in M-CSF receptor signaling |
Q79405603 | Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway |
Q24293488 | ErbB-2 activates Stat3 alpha in a Src- and JAK2-dependent manner |
Q35378767 | Hck is a key regulator of gene expression in alternatively activated human monocytes |
Q42824222 | Low molecular weight protein-tyrosine phosphatase tyrosine phosphorylation by c-Src during platelet-derived growth factor-induced mitogenesis correlates with its subcellular targeting. |
Q31947141 | Lymphokine dependence of STAT3 activation produced by surface immunoglobulin cross-linking and by phorbol ester plus calcium ionophore treatment in B cells |
Q39186157 | Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factor |
Q34462583 | Neoplastic transformation by the gep oncogene, Galpha12, involves signaling by STAT3. |
Q24322037 | PI3-kinase/Akt-dependent antiapoptotic signaling by the PDGF alpha receptor is negatively regulated by Src family kinases |
Q37389005 | Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction |
Q28609164 | Signal transduction via platelet-derived growth factor receptors |
Q73431460 | Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor |
Q40417149 | Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen |
Q42477275 | Stat3 participates in the metabotropic glutamate signaling pathway in Bergmann glial cells |
Q45216903 | Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3'-kinase is important |
Q42831144 | The Src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in platelet-derived growth factor signaling |
Q98170069 | The loss of STAT3 in mature osteoclasts has detrimental effects on bone structure |
Q35126624 | Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells |
Q34627068 | What does Stat3 do? |
Search more.